Related Experiment Video
Updated: Aug 5, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Arrhythmic Risk in Carriers of Predicted Deleterious Rare Variants in Dilated and Arrhythmogenic Cardiomyopathy Genes
Ilaria Gandin1, Andrea Mario Vergani2, Michela Carlotta Massi3
1Biostatistics Unit, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Insights
Rare genetic variants in heart disease genes increase the risk of sudden cardiac death and heart failure, even in individuals without diagnosed heart conditions. These predicted deleterious variants (PDrV) are important prognostic factors.
Area of Science:
- Cardiovascular Genetics
- Population Genomics
- Precision Medicine
Background:
- Monogenic variants in dilated (DCM) and arrhythmogenic cardiomyopathies (ACM) genes are key prognostic factors.
- The role of these variants in the general population is not well understood.
Purpose of the Study:
- To investigate the association between rare, predicted deleterious variants (PDrV) in DCM/ACM genes and cardiac outcomes in the general population.
- To assess the risk of sudden cardiac death/malignant ventricular arrhythmias (SCD/MVA) and heart failure death/heart transplant (HF/HT) in PDrV carriers.
Main Methods:
- Whole-exome sequencing data from the UK Biobank (n=469,671) were analyzed.
- PDrVs in 25 DCM/ACM genes were identified and their association with SCD/MVA and HF/HT events assessed.
- Cause-specific Cox models were used to account for competing risks.
Main Results:
- 2.8% of individuals carried a PDrV.
- PDrV carriers showed an increased risk for SCD/MVA (HR: 1.28) and HF/HT (HR: 1.32).
- In individuals without pre-existing heart disease, PDrV in ACM genes were associated with increased SCD/MVA risk (HR: 1.34).
Conclusions:
- PDrV carriers face a higher risk of severe cardiac events, irrespective of baseline phenotype.
- Variants in ACM genes significantly elevate SCD/MVA risk, even without a DCM diagnosis.
Background:
In dilated (DCM) and arrhythmogenic cardiomyopathies (ACM), monogenic variants in causative genes are key prognostic factors. In the general population, the clinical role of these variants remains debated.
Objectives:
This study aimed to determine the association between rare, predicted deleterious variants (PDrV) in DCM- and ACM-associated genes and disease-related outcomes in the general population.
Methods:
Using United Kingdom Biobank whole-exome sequencing data, we identified PDrVs in 25 DCM/ACM-validated genes. We assessed disease penetrance in carriers and their risk for two primary outcomes-sudden cardiac death/malignant ventricular arrhythmias (SCD/MVA) and heart failure death/heart transplant (HF/HT)-using cause-specific Cox models accounting for competing risks.
Results:
Among 469,671 participants, 54.2% were females and the median age at baseline was 53.5 (IQR: 10.3). During a median follow-up of 14 years (IQR: 2), 5786 SCD/MVA and 4611 HF/HT events occurred. A PDrV was found in 12,973 (2.8%) individuals. Despite low penetrance for DCM (1.0%), PDrV impacted on both outcomes. Compared to noncarriers, PDrV carriers had a higher risk of SCD/MVA (HR: 1.28; 95% CI: 1.11-1.48). In participants free from DCM or other heart diseases at recruitment, SCD/MVA risk was solely associated with ACM genes (HR: 1.34; 95% CI: 1.07-1.69). Carriers also exhibited a higher risk of HF/HT (HR: 1.32; 95% CI: 1.08-1.62), which was not confirmed in subgroup without other heart diseases.
Conclusions:
PDrV carriers have a higher risk of severe cardiac events, even without a clinical overt disease phenotype at baseline evaluation. Moreover, PDrV in arrhythmic genes significantly influence SCD/MVA risk, regardless of phenotypic diagnosis of DCM.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy I: Introduction and Classification
Mechanism of Cardiac Arrhythmias